1932

Abstract

There are two primary types of bone disorders observed in patients with end-stage renal disease: a high-turnover osteodystrophy characterized by osteitis fibrosa, and a low-turnover osteodystrophy characterized initially by osteomalacia and, more recently, by adynamic or aplastic bone disease. This article reviews the clinical presentation, pathogenesis, and laboratory findings of patients with these two disorders. It discusses the important roles of phosphorus binding, vitamin D administration, and correction of acidosis in prevention and treatment of bone disease in patients with moderate renal insufficiency.

Loading

Article metrics loading...

/content/journals/10.1146/annurev.med.48.1.167
1997-02-01
2024-04-24
Loading full text...

Full text loading...

/content/journals/10.1146/annurev.med.48.1.167
Loading
/content/journals/10.1146/annurev.med.48.1.167
Loading

Data & Media loading...

  • Article Type: Review Article
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error